ClinVar Miner

Submissions for variant NM_022124.6(CDH23):c.1660G>A (p.Val554Ile)

gnomAD frequency: 0.00001  dbSNP: rs727504910
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000156295 SCV000206013 uncertain significance not specified 2017-12-26 criteria provided, single submitter clinical testing The p.Val554Ile variant in CDH23 has been identified by our laboratory in 1 indi vidual with sensorineural hearing loss in a heterozygous state. This variant has been identified in 1/28330 South Asian chromosomes by the Genome Aggregation Da tabase (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs727504910). Although t his variant has been seen in the general population, its frequency is not high e nough to rule out a pathogenic role. Computational prediction tools and conserva tion analysis do not provide strong support for or against an impact to the prot ein. In summary, the clinical significance of the p.Val554Ile variant is uncerta in. ACMG/AMP Criteria applied: PM2.
Natera, Inc. RCV001826850 SCV002093622 uncertain significance Usher syndrome type 1 2019-10-28 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.